“Oral Drug May Improve Survival in Men with Metastatic Prostate Cancer”, Duke Cancer Institute

An investigational prostate cancer treatment slows the disease's progression and may increase survival, especially among men whose cancer has spread to the bones, according an analysis led by the Duke Cancer Institute-one of the 23 NCCN Member Institutions....
Source: National Comprehensive Cancer Network - Category: Cancer & Oncology Source Type: news